Induced metabolic bioluminescence imaging (imBI) is an imaging technique which enables detection of various metabolites associated with glycolysis in tumor sections. Signals captured by imBI can be used to chart the topographic distribution of lactate, glucose, pyruvate, and ATP and quantify their absolute amount. ImBi can enable us to perform metabolic classification of tumors as well as to detect metabolic changes in the glycolytic pathway associated with certain therapies, such as anti-angiogenic drugs.
CITATION STYLE
Indraccolo, S., Walenta, S., & Mueller-Klieser, W. (2016). Uncovering metabolic effects of anti-angiogenic therapy in tumors by induced metabolic bioluminescence imaging. In Methods in Molecular Biology (Vol. 1464, pp. 175–184). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3999-2_16
Mendeley helps you to discover research relevant for your work.